HenryGeradMD

Oncology • Findlay, OH

St. Rita's Professional Services

Join to view full profile

Dr. Gerad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gerad's full profile

Already have an account?

Office
15990 Medical Dr S
Findlay, OH 45840
Phone+1 419-422-9898

Fax+1 419-429-0805
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1980 - 1983
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1977 - 1980
Icahn School of Medicine at Mount SinaiClass of 1977

Certifications & Licensure

OH State Medical License 1985 - 2025
PA State Medical License 1978 - 2016
MD State Medical License 1981 - 1984
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

20 citations
Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995.
Michael S. Gordon, Molly L Young, Martin S. Tallman, Larry D. Cripe, John M. Bennett, Elisabeth Paietta, Walter L. Longo, Henry Gerad, Joseph J. Mazza, Jacob M. Rowe> ;Leukemia Research. 2000 Oct 1
30 citations
Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma.
Henry Gerad, David A. Van Echo, Whitacre My, Michael Ashman, Martin Helrich, John Foy, S. Ostrow, Peter H. Wiernik, Joseph Aisner> ;Cancer. 1984 Jun 15
11 citations
An unusual instance of leukemic infiltrate diagnosis and management of periapical tooth involvement
Douglas E. Peterson, Henry Gerad, Lisa T. Williams> ;Cancer. 1983 May 1
47 citations
Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia
Henry Gerad, Merrill J. Egorin, M. Y. Whitacre, David A. Van Echo, Joseph Aisner> ;Cancer Chemotherapy and Pharmacology. 1983 Jan 1
[99mTc-generator eluates: effects on the radiochemical purity of the labelling products].
Schomäcker, K., Gerad, H., Gabruk-Szostak, B., Schicha, H., Malja, S.> ;Nuklearmedizin. 1994 Feb
Phase I-II trial of anthracenedicarboxaldehyde in patients with refractory adult acute leukemia.
Gerad, H., Van Echo, D. A., Donehower, M., Pocelinko, R., Wiernik, P. H.> ;Cancer Treat Rep. 1984 Mar
Join now to see all

Press Mentions

Lima Oncologist Gerad Joins Blanchard Valley Health SystemJanuary 9th, 2017

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Joint Township District Memorial HospitalSaint Marys, Ohio
Licking Memorial HospitalNewark, Ohio
Lima Memorial Health SystemLima, Ohio
Mercer HealthColdwater, Ohio
Mercy Health - St. Rita's Medical CenterLima, Ohio
OhioHealth Van Wert HospitalVan Wert, Ohio
Blanchard Valley HospitalFindlay, Ohio